Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up …
AE Giuliano, K Ballman, L McCall, P Beitsch… - Annals of …, 2016 - journals.lww.com
Methods: ACOSOG Z0011 prospectively examined overall survival of patients with SLN
metastases undergoing breast-conserving therapy randomized to undergo ALND after …
metastases undergoing breast-conserving therapy randomized to undergo ALND after …
[HTML][HTML] Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: Long …
AE Giuliano, K Ballman, L McCall, P Beitsch… - Annals of …, 2016 - ncbi.nlm.nih.gov
Methods ACOSOG Z0011 prospectively examined overall survival of patients with SLN
metastases undergoing breast-conserving therapy randomized to undergo ALND after …
metastases undergoing breast-conserving therapy randomized to undergo ALND after …
[引用][C] Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
AE Giuliano, K Ballman, L McCall, P Beitsch… - Annals of …, 2016 - cir.nii.ac.jp
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary
Dissection in Patients With Sentinel Lymph Node Metastases | CiNii Research CiNii 国立情報学 …
Dissection in Patients With Sentinel Lymph Node Metastases | CiNii Research CiNii 国立情報学 …
Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: Long-term follow-up …
AE Giuliano, K Ballman, L McCall… - Annals of …, 2016 - mdanderson.elsevierpure.com
Abstract Background and Objective: The early results of the American College of Surgeons
Oncology Group (ACOSOG) Z0011 trial demonstrated no difference in locoregional …
Oncology Group (ACOSOG) Z0011 trial demonstrated no difference in locoregional …
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term …
AE Giuliano, K Ballman, L McCall, P Beitsch… - Annals of …, 2016 - europepmc.org
Methods ACOSOG Z0011 prospectively examined overall survival of patients with SLN
metastases undergoing breast-conserving therapy randomized to undergo ALND after …
metastases undergoing breast-conserving therapy randomized to undergo ALND after …
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term …
AE Giuliano, K Ballman, L McCall, P Beitsch… - 2016 - pubmed.ncbi.nlm.nih.gov
Background and objective The early results of the American College of Surgeons Oncology
Group (ACOSOG) Z0011 trial demonstrated no difference in locoregional recurrence for …
Group (ACOSOG) Z0011 trial demonstrated no difference in locoregional recurrence for …
Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: Long-term follow-up …
AE Giuliano, K Ballman, L McCall… - Annals of …, 2016 - utsouthwestern.elsevierpure.com
Abstract Background and Objective: The early results of the American College of Surgeons
Oncology Group (ACOSOG) Z0011 trial demonstrated no difference in locoregional …
Oncology Group (ACOSOG) Z0011 trial demonstrated no difference in locoregional …
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term …
AE Giuliano, K Ballman, L McCall, P Beitsch… - Annals of …, 2016 - europepmc.org
Methods ACOSOG Z0011 prospectively examined overall survival of patients with SLN
metastases undergoing breast-conserving therapy randomized to undergo ALND after …
metastases undergoing breast-conserving therapy randomized to undergo ALND after …